Moneycontrol

Moneycontrol PRO

HomeNewsFy14 revenue guidance

Fy14 Revenue Guidance

Jump to

May surpass FY14 rev guidance by 5%: Dishman Pharma

JR Vyas, CMD, Dishman Pharma said the sale of SEZ land is likely to be concluded in the next fiscal.
Infosys to maintain revenue guidance at 6-10%: Anand Tandon

Talking to CNBC-TV18, Anand Tandon, CEO, JRG Securities says the market is range bound, and as there are no obvious domestic or international triggers, there is no reason why there would be a significant rally. He says there is no reason Infosys should cut its FY14 revenue guidance of 6-10 percent.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347